These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39014499)

  • 21. Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients.
    Zhang X; Yang X; Ji L; Zhang Z
    Int J Rheum Dis; 2019 Jul; 22(7):1278-1282. PubMed ID: 31124267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
    Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
    Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients].
    Ghirardello A; Zampieri S; Iaccarino L; Tarricone E; Tonello M; Bendo R; Rondinone R; Cozzi F; Doria A
    Reumatismo; 2005; 57(1):22-8. PubMed ID: 15776143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and classification of idiopathic inflammatory myopathies.
    Lundberg IE; Miller FW; Tjärnlund A; Bottai M
    J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myositis Autoantibody Profiles and Clinical Significance in Patients with Inflammatory Myopathies in Southwest China.
    Zhu H; Zhou W; Zheng L; Jiang Y; Lao Y; Li S; Jin M; Wang J; Li X
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies.
    Cavazzana I; Richards M; Bentow C; Seaman A; Fredi M; Giudizi MG; Palterer B; Pratesi F; Migliorini P; Franceschini F; Satoh M; Ceribelli A; Mahler M
    J Immunol Methods; 2019 Nov; 474():112661. PubMed ID: 31442464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
    Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
    Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibody testing in idiopathic inflammatory myopathies.
    Rietveld A; Lim J; de Visser M; van Engelen B; Pruijn G; Benveniste O; van der Kooi A; Saris C
    Pract Neurol; 2019 Aug; 19(4):284-294. PubMed ID: 30826741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.
    Tampoia M; Notarnicola A; Abbracciavento L; Fontana A; Giannini M; Louis Humbel R; Iannone F
    J Clin Lab Anal; 2016 Nov; 30(6):859-866. PubMed ID: 27074881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies.
    Rams A; Kosałka-Węgiel J; Kuszmiersz P; Matyja-Bednarczyk A; Polański S; Zaręba L; Bazan-Socha S
    Adv Clin Exp Med; 2021 Dec; 30(12):1239-1248. PubMed ID: 34610217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibody evaluation in idiopathic inflammatory myopathies.
    Tebo AE
    Adv Clin Chem; 2024; 120():45-67. PubMed ID: 38762242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.
    Hou Y; Liu M; Luo YB; Sun Y; Shao K; Dai T; Li W; Zhao Y; Yan C
    Neuromuscul Disord; 2019 Jan; 29(1):5-13. PubMed ID: 30579751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
    Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Torre IG; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG;
    Ann Rheum Dis; 2017 Dec; 76(12):1955-1964. PubMed ID: 29079590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    Tansley SL; Betteridge ZE; Simou S; Jacques TS; Pilkington C; Wood M; Warrier K; Wedderburn LR; McHugh NJ;
    J Rheumatol; 2017 Apr; 44(4):488-492. PubMed ID: 28202739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
    Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
    Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myositis specific autoantibodies as a new diagnostic criterion for idiopathic inflammatory myopathies].
    Kowalska-Oledzka E; Stern LZ
    Neurol Neurochir Pol; 2000; 34(2):339-47. PubMed ID: 10962726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease.
    Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M
    Front Immunol; 2022; 13():866701. PubMed ID: 35603214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.